This week, Beyond Biotech examined why Western pharmaceutical companies have largely overlooked China's advances in circular RNA therapeutics, a potentially significant blind spot in the global biotech landscape. The episode explores the intersection of scientific innovation, market dynamics, and geopolitical factors that have allowed Chinese researchers to move ahead in this space while their Western counterparts remain cautious. Understanding this gap matters for anyone tracking where the next generation of RNA-based treatments might emerge.
Episodes This Week
Get a free sample digest — no signup needed
Real AI summaries from top beyond biotech podcasts, straight to your inbox.
or
No spam, unsubscribe anytime. We'll send one sample digest, then you decide.
Other Weeks
This Week in Beyond Biotech (Sep 14 - Sep 20, 2026)
1 episode · Sep 14 – Sep 20
This Week in Beyond Biotech (Sep 7 - Sep 13, 2026)
1 episode · Sep 7 – Sep 13
This Week in Beyond Biotech (Aug 31 - Sep 6, 2026)
1 episode · Aug 31 – Sep 6
This Week in Beyond Biotech (Aug 24 - Aug 30, 2026)
1 episode · Aug 24 – Aug 30
This Week in Beyond Biotech (Aug 17 - Aug 23, 2026)
1 episode · Aug 17 – Aug 23
This Week in Beyond Biotech (Aug 10 - Aug 16, 2026)
1 episode · Aug 10 – Aug 16
This Week in Beyond Biotech (Jul 27 - Aug 2, 2026)
1 episode · Jul 27 – Aug 2
This Week in Beyond Biotech (Jul 20 - Jul 26, 2026)
1 episode · Jul 20 – Jul 26
This Week in Beyond Biotech (Jul 13 - Jul 19, 2026)
1 episode · Jul 13 – Jul 19
This Week in Beyond Biotech (Jul 6 - Jul 12, 2026)
1 episode · Jul 6 – Jul 12
This Week in Beyond Biotech (Jun 29 - Jul 5, 2026)
1 episode · Jun 29 – Jul 5